Skip Ribbon Commands
Skip to main content
Home Administrative Billing & Reimbursement BlueCard® Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

​​​Updates made to coverage regarding specific techniques for Uterine Fibroid Myolysis​

June 6, 2022

​Independence is updating our position on laparoscopic (i.e., Acessa®) and transcervical (i.e., Sonata®) radiofrequency ablation from Experimental/Investigational to Medically Necessary for Independence and Independence Administrators members.

For detailed information, please refer to these new policies, effective June 6, 2022:

This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of Independence Blue Cross. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.
Connect with us     Facebook     Twitter     Flickr     YouTube     Walk the Talk    Independence Pinterest    Independence LinkedIn    Independence Instagram Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2023 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.